Scientific Program

Note that the proceedings of this conference will be published by Springer as a book (printed and ebook) and will probably appear in June/July 2016.

Conference Program as PDF 

Abstracts of presentations on Friday (including posters): abstracts_Friday

Abstracts of presentations on Saturday: abstracts_Saturday

Day 1  Friday, 22 May 2015

08:30 Paul Werker Opening the conference  
08:35 Jos Aartsen Welcome from the CEO of UMCG  
08:40 Wolfgang Wach & Charles Eaton Welcome from the International Dupuytren Society & the Dupuytren Foundation video
  Session 1 Epidemiology and Patients' Views B. Reichert, Z. Szabo
08:45 Zsolt Szabo Lecture : Treatment of Dupuytren in different countries and the role of FESSH and IFSSH in promoting knowledge for hand surgeons
09:05 Joseph Dias The epidemiology of surgical intervention for Dupuytren Contracture in England video
09:11 Bert Reichert Favorite Options of German Hand Surgeons in the Treatment of Dupuytren Disease video
09:17 Philip Blazar Trends in Dupuytren’s Treatment in the United States video
09:23 Discussion    
09:38 Wolfgang Wach The Patient’s View and Needs – An International Survey: Dupuytren Disease
09:44 Hester Kan Patients’ preferences for treatment for Dupuytren disease: a Discrete Choice Experiment
09:50 Discussion    
  Session 2 Cellular and Extracellular Events
R. Bank, B. Hinz
10:30 David O'Gorman Lecture : The extra­cellular matrix in Dupuytren disease
10:50 Marianna Kruithof‐de Julio
PDGFR-β targeted modified interferon gamma in Dupuytren disease
10:56 Marike van Beuge
Wnt pathway in Dupuytren disease, connecting pro-fibrotic signals
11:02 Ian Clark Biomarkers of post-surgical outcome in Dupuytren disease
11:08 Jagdeep Nanchahal Tumour necrosis factor (TNF) as a therapeutic target in Dupuytren disease
11:14 Discussion    
11:30 David O'Gorman (chair) Controversies 1: Pathogenesis of Dupuytren Disease: active or passive contracture?
11:32 Jagdeep Nanchahal
Active Contracture
11:37 Charles Eaton
Passive Contracture
  Session 3 Genetics and Associations
H. Hennies, R. Ophoff
13:00 Roel Ophoff
Lecture : Genetics in Dupuytren Disease
13:20 Michael Ng
A Large European Genome-wide Association Study Reveals Multiple New Genetic Susceptibility Variants for Dupuytren Disease
13:26 Kerstin Becker Meta-analysis of genome-wide imputed GWAS identifies new significant loci in patients with Dupuytren´s disease
13:32 Juanjiangmeng Du
Identification and characterization of functional genetic variants in Dupuytren Disease
13:38 Discussion    
13:53 Dieuwke Broekstra
A systematic review and meta-analysis on the association between Dupuytren disease and diabetes
13:59 Dieuwke Broekstra The association between vibration and Dupuytren disease: a comparison between elderly field hockey players and controls
14:05 Discussion    
14:15 Ilse Degreef (chair) Controversies 2: The benefit of splinting for Dupuytren contracture  
14:17 Adrian Chojnowski Splinting confers no benefit video
14:22 Wolfgang Wach Splinting is beneficial video
  Session 4 Collagenase Injection
S Coleman,S Wilbrand
15:15 Larry Hurst Lecture : Collagenase Treatment - Journey from Bench to Current Advanced Clinical Use
15:35 Paul Werker Dupuytren Disease in the thumb and first webspace and collagenase treatment video
15:41 Jesper Nordenskjöld
Efficacy of using local anesthesia before collagenase injection in reducing overall pain experience in patients treated for Dupuytren’s contracture: A quasi-randomized study
15:47 Gary M. Pess
Effect of Delayed Finger Extension on the Efficacy and Safety of Collagenase Clostridium Histolyticum Treatment for Dupuytren Contracture
15:51 Massimo Corain
The use of a dynamic dorsal splint for Dupuytren Rehabilitation after collagenase
15:57 Discussion    
16:19 International Dupuytren Society Dupuytren Award 2014 to Clayton Peimer  
16:24 Clayton Peimer Treatment with Collagenase Clostridium Histolyticum: Five-Year CORDLESS Data
16:30 Marie Badalamente
Prospective Multicenter, Multinational Study to Evaluate the Safety and Efficacy of Concurrent Collagenase Clostridium Histolyticum Injections to Treat Two Dupuytren Contractures in the Same Hand
16:36 Marie Badalamente An Open-label, Controlled Phase 2a Study of the Safety and Efficacy of Injectable Collagenase Clostridium Histolyticum (CCH) in Patients with Adhesive Capsulitis (Frozen Shoulder)
16:42 David Warwick Collagenase : what we may never know - a discussion paper
16:48 Discussion    
17:04 Charles Eaton (chair) Controversies 3: The best minimally invasive treatment for Dupuytren Disease:PNF or Collagenase?
17:06 Paul Werker Percutaneous Needle Fasciotomy
17:11 David Warwick Collagenase video
Day 2  Saturday, 23 May 2015  
  Session 5 Assessment / Percutaneous Needle Fasciotomy
U. Lanz, G. Pess
08:30 Joseph Dias MCID for the Patient Evaluation Measure as a Patient Rated Outcome Measure for Dupuytren Contracture
08:36 Chao Zhou Predictors of Satisfaction with Hand Function in Patients with Dupuytren Disease
08:42 Joseph Dias URAMS as a PROM for Dupuytren Contracture Patients
08:48 Discussion    
09:03 Gary Pess Tips and Pearls for Percutaneous Needle Fasciotomy and Collagenase - A Ten Year Personal Experience
09:09 Margot Vlot Percutaneous Needle Fasciotomy for secondary or higher recurrence in Dupuytren disease
09:15 Steven Hovius Extensive Percutaneous Aponeurotomy and Lipofilling versus Limited Fasciectomy in Patients with Primary Dupuytren Contracture; a Randomized Controlled Trial
09:21 Discussion    
09:37 Joseph Dias (chair) Controversies 4: How to treat severe PIP contractures: minimally invasive or surgically?
09:41 Clayton Peimer Minimally invasive methods
09:46 Caroline Leclercq Surgical correction
  Session 6 Comparative Studies / Recurrence
C. Leclercq, D. Elliot
10:45 David Elliot Lecture : Treatment of Dupuytren Disease - Where are we now?
11:05 Paul Binhammer Steroid injection and needle aponeurotomy for Dupuytren disease: long-term follow-up of a randomized controlled trial
11:11 Eva-Maria Baur Minimally invasive treatment of Dupuytren:
Collagenase vs. PNF
11:17 Chao Zhou Collagenase Clostridium Histolyticum versus Partial Fasciectomy for Dupuytren's contracture: Early Outcomes From A Multicenter Propensity-Score Matched Study
11:23 Discussion    
11:35 Jane C Messina Actual Indications of Continuous Extension Technique (TEC) for Severe Dupuytren Disease
11:41 Atanu Biswas
Preliminary soft-tissue distraction versus checkrein ligament release after fasciectomy in the treatment of Dupuytren proximal interphalangeal joint contractures
11:47 Discussion    
11:55 Rinze Zwanenburg
The Palmodigital Spiralling Sheath
12:01 Rosanne Lanting
Clusters in short term disease course in participants with primary Dupuytren Disease
12:07 Discussion    
12:15 Ruud Selles Recurrence after Treatment for Dupuytren Disease; A consensus-based definition
12:21 Caroline Leclercq Recurrence after Dupuytren’s disease:the time factor
12:27 Ilse Degreef Is Recurrence of Dupuytren Disease Prevented by Full-Thickness Grafting Surgery?
12:33 Discussion    
  Session 7 Related disease & Other Treatments
R. Selles, R. Shaffer
13:50 Heinrich Seegenschmiedt Lecture : Radiotherapy for Early Stage
Dupuytren and Ledderhose Disease
14:10 Catherine Ball A Systematic Review Of Non-Surgical Treatments for Early Dupuytren Disease
14:16 Gary Manley The Patient’s View and Needs – An International Survey: Ledderhose Disease
14:22 Discussion    
14:32 Gloria Sue Use of Acellular Dermal Matrix in Dupuytren Disease
14:38 Ilse Degreef In vivo RCT Tension versus compression on Dupuytren
14:44 Discussion    
14:54 Mels van Driel
Lecture : Peyronie's Disease Treatment:
The State of the Art
  Symposia Focus on Research
J. Dias
15:35 Joseph Dias Introduction to the symposia
15:40 David O'Gorman Basic Research: important prerequisites for future studies

D. O'Gorman video

  Ruud Bank We need better methodologies for Dupuytren research video
  Dominic Furniss Requirements for genetic research and novel ways to attract funding video
16:30 Maria Badalamente Clinical Research: international collaboration to execute high powered clinical trials
M. Badalamente video
  Joseph Dias Patient Rated Outcome Measures (PROMS) video
  Charles Eaton International Dupuytren Data Bank (IDDB) video
  Steve Coleman Clinical Research in Australia video
17:20 Paul Werker Closing remarks  



Program Committee


Prof. Paul Werker, UMCG Groningen, The Netherlands

Prof. Joseph Dias, University of Leicester, United Kingdom


Prof. Marie Badalamente, Stony Brook University, New York, USA

Prof. Ulrich Lanz, Klinikum München-Perlach, Munich, Germany

Dr. David O’Gorman, University of Western Ontario, London, Canada


Organizational Board


Prof. Paul Werker, UMCG Groningen, The Netherlands

Dr. Wolfgang Wach, International Dupuytren Society, Übersee, Germany


Dr. Charles Eaton, International Dupuytren Society and Dupuytren Foundation, Palm Springs, USA

Prof. Bert Reichert, Klinikum Nürnberg-Süd, Germany

Christa Verver, Wenckebach Institute, Groningen, The Netherlands




International Conference on Dupuytren Disease and Related Diseases

Groningen, The Netherlands

22 / 23 May 2015


Supported by            Hosted by the

   FESSH            University Medical Center





Endorsed by the Federation of the European Societies for Surgery of the Hand FESSH